Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus

[r]

Purpose: In this study the aim was to investigate adolescents´ attitudes towards physical activity on prescription as a prevention and treatment for cardiovascular disease and type 2

6 CONCLUSIONS Our investigation of the association between risk of CV events and mortality in relation to patients’ refill adherence to lipid-lowering medications and

with type 2 diabetes mellitus (T2DM). Improved control of LDL cholesterol with lipid-lowering medications and patients’ adherence to such medications have been

The present study on type 2 diabetic patients in everyday clinical practice, 18% of which had a history of CVD, showed increased relative risks of CHD (11-13%), stroke (8-9%),

Hazard ratios for coronary heart disease (CHD) and CVD per 1%-unit increase in baseline HbA1c were 1.31 and 1.26 (p<0.001), respectively, when adjusted for age, sex, duration

ISBN 978-91-7833-882-5 (PRINT) ISBN 978-91-7833-883-2 (PDF) http://hdl.handle.net/2077/63285 Printed by Stema Specialtryck AB, Borås. Congenital

The large retrospective cohort design study in paper IV, describing the prevalence, incidence and mortality in patients with CHD and DM over up to 87 years